- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory Primary Mediastinal Large B-Cell Cell Lymphoma in France
Total 562 results
-
Novartis PharmaceuticalsCompletedLymphoma, Non-HodgkinUnited States
-
Regeneron PharmaceuticalsActive, not recruitingChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, United Kingdom, Israel, Germany, France
-
Kite, A Gilead CompanyCompletedRelapsed/Refractory Mantle Cell LymphomaUnited States, Netherlands, Germany, France
-
Affimed GmbHArtiva Biotherapeutics, Inc.RecruitingPeripheral T Cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaUnited States
-
International Extranodal Lymphoma Study Group (IELSG)RecruitingMarginal Zone LymphomaFrance, Italy, Switzerland
-
Kite, A Gilead CompanyCompletedRelapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaUnited States, France, Germany, Netherlands, Canada
-
Millennium Pharmaceuticals, Inc.CompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaUnited States, France, Italy, Poland, United Kingdom, Belgium, Germany, Spain, Belarus, Israel, Portugal, Bulgaria, Turkey, Canada, New Zealand, Peru, Brazil, Russian Federation, Chile, Puerto Rico, Australia, Austria, Hungary, Nether... and more
-
Novartis PharmaceuticalsTerminatedGlioblastoma | Anaplastic Large Cell Lymphoma | Inflammatory Myofibroblastic Tumor | Tumors With Aberrations in ALKFrance, Czechia, Italy, Spain, Korea, Republic of, Thailand, Israel, Denmark
-
Hoffmann-La RocheAbbVieCompletedLymphoma, Non-HodgkinSpain, Hungary, United States, Canada, Australia, Austria, Czechia, France, Italy, Netherlands
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, France, Poland, Belgium, Germany, Spain, Argentina, Colombia, Israel, Portugal, Russian Federation, Turkey, Ukraine, Canada, Greece, Sweden, Korea, Republic of, United Kingdom, Brazil, Mexico, Czechia
-
Janssen Research & Development, LLCPharmacyclics LLC.TerminatedLymphoma, Non-HodgkinUnited States, France, Poland, United Kingdom, Germany, Taiwan, Spain, Bulgaria, Romania, Turkey, Ukraine, Canada, Korea, Republic of, Netherlands, Russian Federation, Belgium, Brazil, Hungary, Czechia, Sweden
-
International Extranodal Lymphoma Study Group (IELSG)RecruitingSplenic Marginal Zone LymphomaSpain, Denmark, France, Norway, Switzerland, Sweden, Italy
-
Kite, A Gilead CompanyActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Indolent Non-Hodgkin LymphomaUnited States, France
-
BeiGeneCompletedMarginal Zone Lymphoma | MZLChina, Australia, Italy, France, New Zealand, Czechia, United Kingdom, United States, Korea, Republic of
-
CelgeneWithdrawnLymphoma, B-CellKorea, Republic of, United States, Spain, Belgium, Taiwan, United Kingdom, Austria, France
-
Step Pharma, SASRecruitingLymphoma, B-Cell | Lymphoma, T-CellUnited States, France, United Kingdom
-
Loxo Oncology, Inc.Eli Lilly and CompanyRecruitingChronic Lymphocytic Leukemia | Leukemia, B-cell | Small Lymphocytic Lymphoma | Leukemia, LymphocyticUnited States, Spain, Canada, Korea, Republic of, Taiwan, Australia, Japan, New Zealand, Italy, Czechia, China, Hungary, Israel, Belgium, France, Poland, Germany, Argentina, United Kingdom, Brazil, Turkey, Chile, Austria
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Italy, Austria, Canada, France, Germany, Japan, Spain, Sweden, United Kingdom
-
French Innovative Leukemia OrganisationJanssen, LPActive, not recruitingRelapsed or Refractory Chronic Lymphocytic LeukemiaFrance
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingLymphoma, B-Cell | Multiple Myeloma | Acute Lymphoblastic Leukemia | Hematologic Malignancy | Car T- CellFrance
-
PfizerCompletedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Carcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung | Malignant Melanoma | Carcinoma, Squamous Cell of Head and NeckUnited States, Australia, Japan, France, Italy
-
Advancell - Advanced In Vitro Cell Technologies...Nexus Oncology LtdCompletedLeukemia, B-Cell, ChronicSpain, France, Belgium
-
The Lymphoma Academic Research OrganisationDaiichi SankyoActive, not recruitingStudy of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell LymphomaLymphoma, B-CellFrance, Belgium
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedLymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic | Disease, HodgkinUnited States, France
-
Hoffmann-La RocheRecruitingNon-Hodgkin's LymphomaBelgium, Australia, Denmark, Spain, Taiwan, France, Italy, United States, Canada, Czechia, New Zealand, Poland, Finland
-
Incyte CorporationActive, not recruitingLymphomaBelgium, United States, France, Israel, Italy, United Kingdom, Germany, Spain, Poland, Australia, Argentina, Denmark
-
International Extranodal Lymphoma Study Group (IELSG)Active, not recruitingSplenic Marginal Zone Lymphoma | Marginal Zone Lymphoma | Nodal Marginal Zone LymphomaFrance, Switzerland, Italy, Belgium, Portugal
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
BayerActive, not recruitingLymphoma,Non-HodgkinChina, Hong Kong, Spain, Taiwan, Turkey, Japan, Russian Federation, Singapore, France, Austria, Bulgaria, Korea, Republic of, Malaysia, Thailand, United States, Hungary, Italy, Poland, Portugal, Germany, Mexico, Romania, Australia, Uk... and more
-
Novartis PharmaceuticalsGlaxoSmithKlineTerminatedNon-Hodgkin's LymphomaChina, United States, Belgium, Czechia, France, Japan, Bulgaria, Canada, Hungary, Peru, Slovakia, South Africa, Ukraine, Korea, Republic of, Puerto Rico, Brazil
-
Versailles HospitalRecruitingT-cell Acute Lymphoblastic Leukemia | Relapsed/Refractory Acute Lymphoblastic LeukemiaFrance
-
Novartis PharmaceuticalsActive, not recruitingNon-Hodgkin LymphomaSpain, Taiwan, Australia, Belgium, Germany, Italy, Singapore, Austria, France, Switzerland, Hong Kong, United States, Netherlands, Norway, United Kingdom, Brazil, China, Japan
-
Janssen Research & Development, LLCRecruitingLymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-CellUnited States, China, France, Denmark, Israel, Poland, Australia
-
AmgenNo longer availableRelapsed/Refractory B-Precursor Acute Lymphoblastic LeukemiaUnited States, Italy, Germany, Austria, France, Switzerland, United Kingdom
-
CelgeneCompletedLymphoma, Non-HodgkinUnited States, Belgium, Germany, Japan, Netherlands, France, Sweden, Italy, Spain, Switzerland, United Kingdom, Finland
-
Astellas Pharma IncCompletedSolid Tumor | B-Cell Lymphoma | Advanced Malignancies | Positive for Anaplastic Lymphoma Kinase | Positive for Proto-Oncogene Tyrosine-Protein Kinase ROSUnited States
-
SecuraBioCompletedA Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO)Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaBelgium, France, Italy, Spain, United States, Austria, New Zealand, Hungary, Germany, United Kingdom, Australia
-
Gilead SciencesTerminatedB-cell Chronic Lymphocytic Leukemia (CLL) With 17p DeletionUnited States, Spain, Denmark, Belgium, Australia, Poland, Romania, Czechia, Italy, France, Hungary, Austria, Portugal, United Kingdom
-
AmgenCompletedType II Refractory Celiac Disease (RCD-II) | In-situ Small Bowel T-cell LymphomaSpain, United States, Finland, France, Netherlands
-
Incyte CorporationActive, not recruitingFollicular Lymphoma | Marginal Zone LymphomaFinland, United States, Spain, Korea, Republic of, Canada, Israel, Turkey, United Kingdom, Netherlands, Greece, Italy, France, Taiwan, Germany, Belgium, Japan, Czechia, Switzerland, Ireland, Poland, Ukraine, Australia, Denmark, Hungary, Swede... and more
-
AmgenCompletedRelapsed/Refractory Philadelphia Positive B-precursor ALLFrance, United States, Germany, Italy, United Kingdom
-
French Innovative Leukemia OrganisationRoche Pharma AG; Janssen-Cilag Ltd.Completed
-
Incyte CorporationActive, not recruitingChronic Lymphocytic Leukemia | Non Hodgkin LymphomaUnited States, Spain, France, Italy, Belgium, Germany, Austria
-
The Lymphoma Academic Research OrganisationCompletedHodgkin Lymphoma | B-Cell LymphomaFrance
-
Janssen Research & Development, LLCActive, not recruitingLymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-CellUnited States, Korea, Republic of, United Kingdom, Taiwan, Israel, Spain, Australia, France
-
SecuraBioCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaBelgium, France, Italy, Spain, United States, Austria, New Zealand, Hungary, United Kingdom, Australia, Germany
-
Fondation Ophtalmologique Adolphe de RothschildCompletedAIDS Related Lymphoma | Central Nervous System LymphomaFrance
-
French National Agency for Research on AIDS and...Hoffmann-La RocheTerminated
-
French Innovative Leukemia OrganisationCompleted
-
CelgeneCompletedRelapsed or Refractory Chronic Lymphocytic LeukemiaUnited States, Canada, United Kingdom, France, Germany, Spain, Italy, Sweden